Disclosure Of Fair Value Measurement [Text Block]

GenSight Biologics S.A. - Filing #5982864

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of fair value measurement [text block]
3
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
10 756 EUR
9,132,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
206 606 EUR
26 920 EUR
3 119 EUR
222 644 EUR
14 001 EUR
190,937,000 EUR
1,633,000 EUR
30,702,000 EUR
197,051,000 EUR
26,220,000 EUR
15,279,000 EUR
181,211,000 EUR
1,158,000 EUR
170,024,000 EUR
27,625,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.